November 06, 2025: US Food & Drug Administration (FDA) grants clearance to AIOMEGA's AIO Breathe® PDS Pediatric Oral Appliance for treating mild/moderate OSA and snoring in 6 - 17-year-old children. AIO Breathe® PDS is the world's first and only AAVOAT (Adaptive Antero-Vertical Open Airway Therapy) to receive this distinction. The pediatric version features identical design, engineering, and therapeutic technology as the adult device—offering a seamless adaptation to the growing pediatric patient population with OSA.Subscribe →